We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock
search icon
We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock

Menu

Moxifloxacin

Moxifloxacin | CAS NO: 151096-09-2, It's important to note that moxifloxacin should only be used for bacterial infections and not for viral infections (such as the common cold or flu). It should also be taken as prescribed, as overuse or misuse of antibiotics can lead to antibiotic resistance.

We are the Synchemia Research Chemical specializes in manufacturing and supplying of Moxifloxacin impurities that meet specific pharmacopeial standards (EP/BP/USP/IP) as well as process-related impurities Community-acquired pneumonia (CAP): It is commonly used to treat pneumonia caused by bacteria. Chronic obstructive pulmonary disease (COPD) exacerbations: It helps in treating bacterial infections that worsen COPD. Acute bacterial sinusitis: For infections of the sinuses caused by bacteria. Buy Reliable and High-Purity Moxifloxacin Impurities, Delivered by Synchemia Research Chemicals.

download image Download catalogue

Pharmaceutical Reference Standards

Moxifloxacin 7-Amino Impurity
Moxifloxacin 7-Amino Impurity
CAT No SRC-M13167
CAS No 172426-88-9
Mol.F. C14H13FN2O4
Mol.Wt. 292.3 g/mol
INV STATUS CUSTOM SYNTHESIS

Let’s advance your research together.

Partner with us for specialized chemical materials and synthesis services that enable pharmaceutical innovation.